Proton pump inhibitors are a class of medications used to treat conditions like GERD and ulcers. They work by blocking the ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The decision makes it impossible to guess what might come next for the healthcare industry. Robert F. Kennedy Jr. is unlike ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...

Just four days before the opening of the CIIE, the latest version of China's negative list for foreign investment ... At its ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where the 7th China International Import Expo (CIIE) is being held, people from ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Global Inhalable Drugs market size is expected to reach US$ 56.68 Bn by 2030, from US$ 34.86 Bn in 2023, exhibiting a CAGR of 7.2% during the forecast period. Mr. Shah Coherent Market Insights Pvt.